EDGAR Filing Documents for 0001813747-20-000001

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001813747-20-000001

Filing Date

2020-06-18

Accepted

2020-06-18 15:28:42

Documents

Effectiveness Date

2020-06-18

Items

Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	9400
	Complete submission text file	0001813747-20-000001.txt		10562

Mailing Address 835 GEORGIA AVENUE SUITE 800 CHATTANOOGA TN 37402

Business Address 835 GEORGIA AVENUE SUITE 800 CHATTANOOGA TN 37402 (423) 648-7894

Solas BioVentures Fund II, LP (Filer) CIK: 0001813747 (see all company filings)